BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2532141)

  • 1. Human marginal zone B cells are not an activated B cell subset: strong expression of CD21 as a putative mediator for rapid B cell activation.
    Timens W; Boes A; Poppema S
    Eur J Immunol; 1989 Nov; 19(11):2163-6. PubMed ID: 2532141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
    Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
    J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
    Boackle SA; Morris MA; Holers VM; Karp DR
    J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex.
    Carter RH; Tuveson DA; Park DJ; Rhee SG; Fearon DT
    J Immunol; 1991 Dec; 147(11):3663-71. PubMed ID: 1719083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of germinal center B cell differentiation. Role of the human APO-1/Fas (CD95) molecule.
    Lagresle C; Bella C; Daniel PT; Krammer PH; Defrance T
    J Immunol; 1995 Jun; 154(11):5746-56. PubMed ID: 7538529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CD19/CD21 signal transducing complex of human B lymphocytes includes the target of antiproliferative antibody-1 and Leu-13 molecules.
    Bradbury LE; Kansas GS; Levy S; Evans RL; Tedder TF
    J Immunol; 1992 Nov; 149(9):2841-50. PubMed ID: 1383329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase.
    Willenbrock K; Jungnickel B; Hansmann ML; Küppers R
    Eur J Immunol; 2005 Oct; 35(10):3002-7. PubMed ID: 16180254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice.
    Takahashi K; Kozono Y; Waldschmidt TJ; Berthiaume D; Quigg RJ; Baron A; Holers VM
    J Immunol; 1997 Aug; 159(3):1557-69. PubMed ID: 9233655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD22 regulates thymus-independent responses and the lifespan of B cells.
    Otipoby KL; Andersson KB; Draves KE; Klaus SJ; Farr AG; Kerner JD; Perlmutter RM; Law CL; Clark EA
    Nature; 1996 Dec 19-26; 384(6610):634-7. PubMed ID: 8967951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody class switching differs among SJL, C57BL/6 and 129 mice.
    Kaminski DA; Stavnezer J
    Int Immunol; 2007 Apr; 19(4):545-56. PubMed ID: 17329233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CR2 ligands modulate human B cell activation.
    Bohnsack JF; Cooper NR
    J Immunol; 1988 Oct; 141(8):2569-76. PubMed ID: 2459218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells.
    Ferguson AR; Youd ME; Corley RB
    Int Immunol; 2004 Oct; 16(10):1411-22. PubMed ID: 15326094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expansion of functionally anergic CD21-/low marginal zone-like B cell clones in hepatitis C virus infection-related autoimmunity.
    Terrier B; Joly F; Vazquez T; Benech P; Rosenzwajg M; Carpentier W; Garrido M; Ghillani-Dalbin P; Klatzmann D; Cacoub P; Saadoun D
    J Immunol; 2011 Dec; 187(12):6550-63. PubMed ID: 22084433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferation and differentiation of human CD5+ and CD5- B cell subsets activated through their antigen receptors or CD40 antigens.
    Defrance T; Vanbervliet B; Durand I; Briolay J; Banchereau J
    Eur J Immunol; 1992 Nov; 22(11):2831-9. PubMed ID: 1385152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immaturity of the human splenic marginal zone in infancy. Possible contribution to the deficient infant immune response.
    Timens W; Boes A; Rozeboom-Uiterwijk T; Poppema S
    J Immunol; 1989 Nov; 143(10):3200-6. PubMed ID: 2478621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-bet-positive and IRTA1-positive monocytoid B cells differ from marginal zone B cells and epithelial-associated B cells in their antigen profile and topographical distribution.
    Jöhrens K; Shimizu Y; Anagnostopoulos I; Schiffmann S; Tiacci E; Falini B; Stein H
    Haematologica; 2005 Aug; 90(8):1070-7. PubMed ID: 16079106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD77: an antigen of germinal center B cells entering apoptosis.
    Mangeney M; Richard Y; Coulaud D; Tursz T; Wiels J
    Eur J Immunol; 1991 May; 21(5):1131-40. PubMed ID: 1709864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Undetectable CD40 ligand expression on T cells and low B cell responses to CD40 binding agonists in human newborns.
    Durandy A; De Saint Basile G; Lisowska-Grospierre B; Gauchat JF; Forveille M; Kroczek RA; Bonnefoy JY; Fischer A
    J Immunol; 1995 Feb; 154(4):1560-8. PubMed ID: 7530739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytokine dependency of human B cell cycle progression elicited by ligands which coengage BCR and the CD21/CD19/CD81 costimulatory complex.
    Mongini PK; Inman JK
    Cell Immunol; 2001 Feb; 207(2):127-40. PubMed ID: 11243702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.